Navigation Links
NUCRYST Approves $0.80 Per Share Cash Distribution to Shareholders
Date:2/12/2009

PRINCETON, NJ, Feb. 12 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals Corp., a developer and manufacturer of medical products that fight infection and inflammation, today announced the results of a special meeting of shareholders. The special meeting of shareholders was called to consider a special resolution ("Special Resolution") pursuant to section 38(1) of the Business Corporations Act (Alberta) to reduce the stated capital of the outstanding NUCRYST common shares by an amount equal to the product of the number of common shares outstanding on the date of the meeting and $0.80 for the purpose of distributing $0.80 cash per share to the common shareholders of NUCRYST.

The distribution which will total $14.7 million equals approximately 59% of NUCRYST's $25.0 million in cash and cash equivalents as of January 31, 2009. NUCRYST set a distribution payable date of February 25, 2009.

The Special Resolution was passed and February 17, 2009 was set as the record date for the distribution. The Toronto Stock Exchange ("TSX") has determined that mandatory special settlement rules will be applied and the common shares will commence trading ex-distribution on the TSX at the opening of the markets on February 17, 2009.

Under NASDAQ OMX rules, the shares will continue to trade with the distribution until its ex-distribution date of February 26, 2009.

NUCRYST also announced the resignation of Thomas E. Gardner from the Board of Directors, effective immediately. Mr. Gardner previously served as Chairman, President, & Chief Executive Officer of NUCRYST until January 2009.

NUCRYST will release its 2008 fourth quarter and full year financial results on Tuesday, February 17, 2009. A conference call will be held that morning to discuss the financial results as well as the impact of the return of capital on NUCRYST's business plans.

All amounts are in U.S. dollars.

About NUCRYST Pharmaceuticals Corp.


'/>"/>

SOURCE NUCRYST Pharmaceuticals Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. NUCRYST and Smith & Nephew Revise Agreements
2. Webcast Advisory - NUCRYST Pharmaceuticals Webcast of Conference Call to Discuss 2007 Third Quarter Results
3. NUCRYST Pharmaceuticals announces 2007 third quarter results
4. NUCRYST Pharmaceuticals announces year-end results
5. NUCRYST Announces Senior Management Change
6. NUCRYST Announces Management Realignment and R&D Portfolio Change
7. NUCRYST Announces First Quarter 2008 Financial Results
8. NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer
9. NUCRYST Pharmaceuticals to Release Second Quarter 2008 Financial Results on Tuesday, August 12, 2008
10. NUCRYST Receives Deficiency Notice from NASDAQ
11. The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/5/2015)... (PRWEB) , ... July 05, 2015 , ... Women's ... their studio in Lake Orion. These classes are geared towards families that want ... the summer break. , The fitness class will take place TUESDAYS at ...
(Date:7/5/2015)... PA (PRWEB) , ... July 05, 2015 , ... ... of patented products, announces the Weed Master, a landscaping invention that effectively ... worth $75 billion US dollars," says Scott Cooper, CEO and Creative Director of ...
(Date:7/5/2015)... ... July 05, 2015 , ... Women’s Excellence in Wellness, ... Lake Orion location. The special consists of 2 months of unlimited classes for just ... Movestrong is located at 1410 South Lapeer Road in Lake Orion. ...
(Date:7/5/2015)... , ... July 05, 2015 , ... Doctors at the ... new IMRT/surgery combination may one day change the outlook for people with pleural mesothelioma. ... now. , Researchers report that five mesothelioma patients treated with 25Gy of ...
(Date:7/4/2015)... ... July 05, 2015 , ... Dating a real millionaire online can be ... millionaire dating service and strives to remove the worries from meeting partners. Recently, ... dating app of 2015 and readers have responded with excitement. , “There's ...
Breaking Medicine News(10 mins):Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5Health News:New Mesothelioma Study Calls IMRT/Surgery Combo “Innovative and Promising”, According to Surviving Mesothelioma 2Health News:MillionaireMatchapp.com Publishes the Best Millionaire Dating App and Official Dating Site Reviews 2015 2
... fatigue is often a major problem for cancer ... completing therapy. Researchers at Mayo Clinic ( http://www.mayoclinic.org/oncology-rst/ ... ( http://ncctg.mayo.edu/ ) (NCCTG) recently completed a study ... and found that, while it did not improve ...
... M.D., Ph.D., FASTRO, and William McBride, D.Sc., Ph.D., have ... Oncology,s most prestigious award, the Gold Medal. They will ... during ASTRO,s 52nd Annual Meeting, taking place October 31 ... Medal is bestowed on revered members who have made ...
... ... targeted internet traffic to their websites. The solution is all in the PT Marketing Academy. ... to use WordPress blogs, search engine optimization for Google search, Facebook, Twitter, YouTube, and all ... ...
... Montreal, Quebec June 2, 2010 Baby boomers retiring ... in Canada or the U.S., however, a study suggests retirees ... and from the mainstream of Mexican life. The study, ... presented at the 2010 Congress for the Humanities and Social ...
... current problem is the mission of analytical chemistry, according to ... the University of the Basque Country (UPV/EHU). The group,s name ... these problems - Farmartem: the abbreviation in Spanish of pharmaceuticals, ... Art has been the line of research least worked on ...
... after mastectomy fared better, researchers say , WEDNESDAY, June ... after a mastectomy may influence the odds of breast ... the Catholic University of Louvain (Leuven) in Belgium looked ... in 327 women from one to four years after ...
Cached Medicine News:Health News:Results from a study testing methylphenidate for cancer-related fatigue 2Health News:Results from a study testing methylphenidate for cancer-related fatigue 3Health News:Larson, McBride named 2010 ASTRO Gold Medalists 2Health News:New Online Physical Therapy Marketing Academy Helps Physical Therapists Conquer The Web 2Health News:New Online Physical Therapy Marketing Academy Helps Physical Therapists Conquer The Web 3Health News:New Online Physical Therapy Marketing Academy Helps Physical Therapists Conquer The Web 4Health News:New Online Physical Therapy Marketing Academy Helps Physical Therapists Conquer The Web 5Health News:Retirees in Mexico cut off, study says 2Health News:Basque researchers apply chemistry to restoration of paintings and dating of signatures 2Health News:Basque researchers apply chemistry to restoration of paintings and dating of signatures 3
(Date:7/4/2015)... BARCELONA , España, July 4, 2015 /PRNewswire/ ... SIR-Spheres® Y-90 a la quimioterapia de primera línea ... en el hígado (mCRC) extiende la supervivencia libre ... pacientes con cáncer colorrectal metastásico no resecable (mCRC) ... la mayor mejora en la supervivencia libre de ...
(Date:7/4/2015)... BARCELONA , Spanje, July 4, 2015 ... SIR-Spheres® Y-90 harsmicrosferen aan eerstelijns chemotherapie voor ... de lever (mCRC) verlengt de progressievrije overleving ... met niet-resectabele, gemetastaseerde colorectale kanker (mCRC) die ... grootste verbetering gezien in progressievrije overleving (PFS) ...
(Date:7/4/2015)... Spain , July 4, 2015 ... first-line chemotherapy for patients with unresectable metastatic colorectal ... Survival in that organ Patients with ... only to the liver experienced the greatest improvement ... the addition of SIR-Spheres Y-90 resin microspheres to ...
Breaking Medicine Technology:El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 2El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 3El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 4El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 5Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 2New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 4
... Dec. 27, 2010 King Pharmaceuticals®, Inc. (NYSE: ... PTIE ) today announced that King has resubmitted a ... Food and Drug Administration (FDA) in response to a Complete ... is a Class 2 resubmission with a six month review ...
... Cepheid (Nasdaq: CPHD ) today announced ... investor conference, and invited investors to participate via webcast.J. ... a.m. Pacific TimeTo access the live webcast for this ... at least 15 minutes before the scheduled start time ...
Cached Medicine Technology:King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY® 2King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY® 3Cepheid to Webcast Upcoming Financial Presentation 2
... gives you the exceptional performance you need at ... illumination, comfort and durability youd expect from headlights ... headlight. It features our thinnest cable and adjusts ... flexibility. Now when you reach for a headlight ...
... XENION operating lamp offers a light output ... light field diameter. The innovative lamp also ... An additional advantage of the fascinating gas ... This is top technology, setting new standards ...
Advanced Lighting System with Multi-Lamp Design providing Surgeon Focus Control and Extended, Variable Depth of Field over greater working distances. High Intensity, Cool Beam Temperature...
Dual Flatscreen Monitor Mounts (with Skytron Surgical Lights)...
Medicine Products: